Prospective 1-year follow-up study of all cured, new sputum smear positive tuberculosis patients under the Revised National Tuberculosis Control Program in Hyderabad, Telangana State, India.

Mathur, Neeta; Chatla, Chakrapani; Syed, Saba; Patel, Yogesh; Pattnaik, Snigdha; Mathai, Dilip; Rajesham, Adepu

Mathur, Neeta; Chatla, Chakrapani; Syed, Saba; Patel, Yogesh; Pattnaik, Snigdha; Mathai, Dilip; Rajesham, Adepu.

Afiliación

Mathur N; Department of Community Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India.
Chatla C; WHO-RNTCP Technical Support Program, WHO India Country Office, New Delhi, India.
Syed S; Department of Community Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India.
Patel Y; WHO-RNTCP Technical Support Program, WHO India Country Office, New Delhi, India.
Pattnaik S; Department of Community Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India.
Mathai D; Department of General Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India.
Rajesham A; Revised National Tuberculosis Control Program, Government of Telangana, India.

Lung India ; 36(6): 519-524, 2019.

Article en En | MEDLINE | ID: mdl-31670300

Palabras clave

Follow-up; Revised National Tuberculosis Control Program; health status; new sputum smear positive (NSP); posttreatment survival; tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Idioma: En Revista: Lung India Año: 2019 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google